NCT07047261

Brief Summary

The peri-implant mucositis is an inflammatory and reversible lesion that surrounds the peri-implant mucosa without loss of supporting bone, clinically characterized by bleeding on gentle probing. It has been estimated that it affects approximately 21% to 88% of individuals and 9% to 51% of implant sites, with prevalences of 47% and 29%, respectively. Experimental clinical researches show that peri-implant mucositis can be reversed if proper biofilm management is maintained. Prevention and regression of inflammation around the implant can be achieved through proper oral hygiene and an effective supportive care protocol, which may include regular clinical check-ups, radiographic assessments, oral hygiene instructions and professional mechanical plaque removal (PMPR). Therefore, adjunctive measures such as self-administration of oral rinse antiseptics (i.e. chlorhexidine) may be considered. For examples, the use of a chlorhexidine-based gel in combination with xanthan (XanCHX), in addition to PMPR has demonstrated clinical improvements in the treatment of periodontitis. The aim of the present study was to investigate the potential benefits of XanCHX gel in adjunction to PMPR in patients affected by peri-implant mucositis, promoting a complete healing of the affected tissues.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 29, 2026

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

June 17, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Peri-implant mucositisadjunctive treatmentprofessional mechanical plaque removalXanthan-chlorhexidine based gel

Outcome Measures

Primary Outcomes (1)

  • Bleeding on Probing

    Presence or absence of gingival bleeding within 30 seconds after probing

    From baseline until the end of the study (6 months)

Secondary Outcomes (5)

  • Probing pocket depth

    From the baseline until the end of the study (6 months)

  • Plaque index

    From baseline until the end of the study (6 months)

  • Gingival recession

    From the baseline until the end of the study (6 months)

  • Keratinized gingiva

    From the baseline until the end of the study (6 months)

  • Clinical attachment level

    From the baseline until the end of the study (6 months)

Study Arms (2)

Professional mechanical plaque removal with xanthan-chlorhexidine based gel

EXPERIMENTAL

At baseline, after recording clinical parameters, patients received oral hygiene instruction and underwent periodontal debridement alternating ultrasonic with manual instruments, followed by the use of air-abrasive devices with 25-micron glycine powder and a supragingival tip Subsequently, the clinician cleaned and dried the site using compressed air and applied the XanCHX gel on the implant sites assigned to the test group, positioning the blunt needle at the bottom of the pocket and gently extruding the product while moving it out of the site. Finally, the patient was instructed not to drink or rinse for the following hour. At each time-step, clinical assessments were recorded after the reinforcement in oral hygiene instruction and professional implant hygiene using rubber cup and polishing paste.

Procedure: Adjunctive use of Xanthan-Chlorexidine based gel

Professional mechanical plaque removal alone

NO INTERVENTION

At baseline, after recording clinical parameters, patients received oral hygiene instruction and underwent periodontal debridement alternating ultrasonic with manual instruments, followed by the use of air-abrasive devices with 25-micron glycine powder and a supragingival tip. At each time-step, clinical assessments were recorded after the reinforcement in oral hygiene instruction and professional implant hygiene using rubber cup and polishing paste.

Interventions

The chlorhexidine and xanthan-based gel contains 0.5% chlorhexidine digluconate, 1% chlorhexidine dihydrochloride, and 0.5% xanthan gel. Xanthan is a polymer that creates a three-dimensional, pseudo-plastic network with water, forming a stable gel that allows a slow and prolonged release of chlorhexidine, allowing effectiveness for about 30 days. Chlorhexidine digluconate is released immediately upon application, whereas Chlorhexidine dihydrochloride is gradually delivered the following days, providing bacteriostatic and bactericidal effects for up to two weeks, helping the prevention of recolonization of treated site. The clinician cleaned and dried the implant site using compressed air and applied the XanCHX gel on the implant sites assigned to the test group, positioning the blunt needle at the bottom of the pocket and gently extruding the product while moving it out of the site. Finally, the patient was instructed not to drink or rinse for the following hour.

Professional mechanical plaque removal with xanthan-chlorhexidine based gel

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of two or more peri-implant mucositis sites (e.g. presence of bleeding and/or suppuration on probing with no bone loss evident on radiographs);
  • implant-supported fixed restorations inserted at least 6 months before patient enrollment

You may not qualify if:

  • radiation therapy in the head and neck therapy or long-term corticosteroid treatments;
  • use of systemic antibiotics for more than 6 months;
  • diagnosis of not plaque-associated inflammatory diseases (e.g., Oral Lichen Planus);
  • pregnant or breastfeeding mother;
  • untreated peri-implantitis;
  • oral rehabilitation with full-arch prostheses;
  • allergy to chlorhexidine and/or other components contained in the gel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Città della Salute e della Scienza

Torino, Italy, 10126, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dental Hygienist Registered (RDH)

Study Record Dates

First Submitted

June 17, 2025

First Posted

July 2, 2025

Study Start

February 14, 2025

Primary Completion

August 30, 2025

Study Completion

September 1, 2025

Last Updated

April 29, 2026

Record last verified: 2025-06

Locations